C34
Conditions
Interventions
Group 1: Blood draw from patients with suspected lung tumor
Group 2: Blood draw from patients undergoing bronchoscopic evaluation of suspected non-malignant pulmonary diseases.
Sponsors
Hummingbird Diagnostics GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Male or female with presumable pathological findings through X-ray/CT 2. Signed informed consent 3. Patient is at least 18 years old
Exclusion criteria
Exclusion criteria: 1. History of other primary malignancies 2. Medication that influences the immune system (e.g. immunosuppressive drugs) 3. Patient is younger than 18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Validation of a previously identified signature of blood-based miRNA biomarkers for the identification of lung tumors. After measuring miRNA expression levels, it will be tested whether the signature can be used to discriminate between the two cohorts and if the results are comparable to previous tests. | — |
Secondary
| Measure | Time frame |
|---|---|
| Testing the potential of a previously identified signature of blood-based miRNA biomarkers for lung cancer screening. | — |
Countries
Germany
Contacts
Public ContactStephan Walterspacher
Klinikum Konstanz Lungenzentrum / II. Medizinische Klinik
Outcome results
None listed